CVM
Price
$6.86
Change
+$0.57 (+9.06%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
35.17M
SNDX
Price
$10.00
Change
-$0.22 (-2.15%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
859.61M
18 days until earnings call
Interact to see
Advertisement

CVM vs SNDX

Header iconCVM vs SNDX Comparison
Open Charts CVM vs SNDXBanner chart's image
Cel-Sci
Price$6.86
Change+$0.57 (+9.06%)
Volume$5.82K
Capitalization35.17M
Syndax Pharmaceuticals
Price$10.00
Change-$0.22 (-2.15%)
Volume$31.94K
Capitalization859.61M
CVM vs SNDX Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.5B. The market cap for tickers in the group ranges from 58 to 309.36B. NONOF holds the highest valuation in this group at 309.36B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 6%. For the same Industry, the average monthly price growth was 18%, and the average quarterly price growth was 29%. AAVXF experienced the highest price growth at 794%, while REPL experienced the biggest fall at -74%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 106%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -3 (-100 ... +100)

Notable companies

The most notable companies in this group are Cel-Sci Corp (ASE:CVM).

Market Cap

The average market capitalization across the group is 455.85M. The market cap for tickers in the group ranges from 32.3M to 879.4M. SNDX holds the highest valuation in this group at 879.4M. The lowest valued company is CVM at 32.3M.

High and low price notable news

The average weekly price growth across all stocks in the group was 37%. For the same group, the average monthly price growth was 83%, and the average quarterly price growth was -39%. CVM experienced the highest price growth at 63%, while SNDX experienced the biggest fall at 10%.

Volume

The average weekly volume growth across all stocks in the group was 20%. For the same stocks of the group, the average monthly volume growth was 169% and the average quarterly volume growth was 613%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 91
P/E Growth Rating: 28
Price Growth Rating: 52
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: 0 (-100 ... +100)
VS
CVM vs. SNDX commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Buy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (CVM: $6.29 vs. SNDX: $10.22)
Brand notoriety: CVM: Notable vs. SNDX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 65% vs. SNDX: 82%
Market capitalization -- CVM: $35.17M vs. SNDX: $859.61M
CVM [@Biotechnology] is valued at $35.17M. SNDX’s [@Biotechnology] market capitalization is $859.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CVM and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 6 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • CVM’s TA Score: 6 bullish, 3 bearish.
  • SNDX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CVM is a better buy in the short-term than SNDX.

Price Growth

CVM (@Biotechnology) experienced а +63.38% price change this week, while SNDX (@Biotechnology) price change was +10.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.88%. For the same industry, the average monthly price growth was +18.15%, and the average quarterly price growth was +28.82%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

SNDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+5.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($860M) has a higher market cap than CVM($35.2M). SNDX YTD gains are higher at: -22.693 vs. CVM (-47.570). CVM has higher annual earnings (EBITDA): -21.96M vs. SNDX (-318.27M). SNDX has more cash in the bank: 516M vs. CVM (1.92M). SNDX has less debt than CVM: SNDX (1.84M) vs CVM (10.5M). SNDX has higher revenues than CVM: SNDX (43.7M) vs CVM (0).
CVMSNDXCVM / SNDX
Capitalization35.2M860M4%
EBITDA-21.96M-318.27M7%
Gain YTD-47.570-22.693210%
P/E RatioN/AN/A-
Revenue043.7M-
Total Cash1.92M516M0%
Total Debt10.5M1.84M572%
FUNDAMENTALS RATINGS
CVM vs SNDX: Fundamental Ratings
CVM
SNDX
OUTLOOK RATING
1..100
114
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4064
P/E GROWTH RATING
1..100
533
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNDX's Valuation (84) in the Biotechnology industry is in the same range as CVM (98). This means that SNDX’s stock grew similarly to CVM’s over the last 12 months.

SNDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CVM (100). This means that SNDX’s stock grew similarly to CVM’s over the last 12 months.

SNDX's SMR Rating (98) in the Biotechnology industry is in the same range as CVM (100). This means that SNDX’s stock grew similarly to CVM’s over the last 12 months.

CVM's Price Growth Rating (40) in the Biotechnology industry is in the same range as SNDX (64). This means that CVM’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's P/E Growth Rating (3) in the Biotechnology industry is somewhat better than the same rating for CVM (53). This means that SNDX’s stock grew somewhat faster than CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMSNDX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOD98.804.97
+5.30%
Modine Manufacturing Co
DSGN4.270.02
+0.47%
Design Therapeutics
FSM6.97-0.01
-0.14%
Fortuna Mining Corp
NTWK4.12-0.03
-0.72%
NetSol Technologies
COIN397.81-6.63
-1.64%
Coinbase Global

CVM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+19.35%
NRXS - CVM
58%
Loosely correlated
-3.50%
MDGL - CVM
43%
Loosely correlated
-2.12%
CYTK - CVM
40%
Loosely correlated
+0.61%
ADXN - CVM
39%
Loosely correlated
+6.90%
EYPT - CVM
38%
Loosely correlated
+2.39%
More

SNDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-0.87%
IDYA - SNDX
54%
Loosely correlated
+7.31%
CGON - SNDX
54%
Loosely correlated
-2.16%
REPL - SNDX
51%
Loosely correlated
+18.89%
ETNB - SNDX
51%
Loosely correlated
+1.00%
RNA - SNDX
50%
Loosely correlated
+1.16%
More